Free Trial

MEI Pharma (MEIP) Earnings Date, Estimates & Call Transcripts

MEI Pharma logo
$3.07
-0.03 (-0.97%)
(As of 11/1/2024 ET)

MEI Pharma Latest Earnings Summary

Upcoming Q1
Earnings Date
Nov. 14Estimated
Actual EPS
(Sep. 19)
-$1.13 Beat By $0.35
Consensus EPS
(Sep. 19)
-$1.48

MEI Pharma announced Q4 2024 earnings on September 19, 2024, reporting an EPS of -$1.13, which topped the consensus estimate of -$1.48 by $0.35. With a trailing EPS of $2.67 and a P/E Ratio of 1.15, MEI Pharma's earnings are expected to grow next year, from ($5.10) to ($3.71) per share.

MEIP Upcoming Earnings

MEI Pharma's next earnings date is estimated for Thursday, November 14, 2024, based off prior year's reporting schedules.

Get MEI Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MEI Pharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MEIP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MEIP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MEI Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$1.47-$1.47-$1.47
Q2 20241-$1.52-$1.52-$1.52
Q3 20241-$1.42-$1.42-$1.42
Q4 20241-$1.56-$1.56-$1.56
FY 20244-$5.97-$5.97-$5.97
Q1 20251-$1.64-$1.64-$1.64
Q2 20251-$1.72-$1.72-$1.72

MEI Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/14/2024
(Estimated)
------- 
9/19/2024Q4 2024-$1.48-$1.13+$0.35$0.50--
5/9/2024Q3 2024-$1.38-$1.37+$0.01-$1.37--
2/13/2024Q2 2024-$1.46-$1.66 -$0.20-$1.66--
11/9/2023Q1 2024-$1.47$8.46+$9.93$8.46-$65.30M
9/26/2023Q4 2023-$3.25-$1.51+$1.74-$1.51$0.75M$1.46M
5/11/2023Q3 2023-$2.60-$2.32+$0.28-$2.32$0.98M$5.89M
2/9/2023Q2 2023-$3.20$1.60+$4.80$0.08$9.69M$32.74M
11/14/2022Q1 2023-$2.60-$2.60--$0.14$9.75M$8.73M

MEI Pharma Earnings - Frequently Asked Questions

MEI Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on MEIP's earnings history.

In the previous quarter, MEI Pharma (NASDAQ:MEIP) reported ($1.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.48) by $0.35. Learn more on analysts' earnings estimate vs. MEIP's actual earnings.

MEI Pharma (NASDAQ:MEIP) has a recorded annual revenue of $65.30 million.

MEI Pharma (NASDAQ:MEIP) has a recorded net income of $17.78 million. MEIP has generated $2.67 earnings per share over the last four quarters.

MEI Pharma (NASDAQ:MEIP) has a trailing price-to-earnings ratio of 1.15.

MEI Pharma's earnings are expected to grow from ($5.10) per share to ($3.71) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:MEIP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners